Meetings: National Institute of Diabetes and Digestive and Kidney Diseases,
FR, March 26, 2003 › Notices › National Institutes of Health
Linked as:FR, March 26, 2003 › Notices › National Institutes of Health
Linked as:Text
Federal Register: March 26, 2003 (Volume 68, Number 58)NoticesPage 14677From the Federal Register Online via GPO Access [wais.access.gpo.gov]
DOCID:fr26mr03-116
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel, Multi-Site Trial of Azathioprine Dosing in Crohn Disease.
Date: April 2, 2003.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Neal A. Musto, PhD, Scientific Review Administrator, Review Branch, DEA, NIDDK, Room 751, 6707 Democracy Boulevard, National Institutes of Health, Bethesda, MD 20892-6600, (301) 594-7798, muston@extra.niddk.nih.gov.
This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.
Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel, Treatment Affect Cognition in Type 1 Diabetes.
Date: April 28, 2003.
Time: 9:30 a.m. to 11 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Maria E. Davila-Bloom, PhD, Scientific Review Administrator, Review Branch, DEA, NIDDK, Room 758, 6707 Democracy Boulevard, National Institutes of Health, Bethesda, MD 20892, 301- 594-7637, davila-bloomm@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS)
Dated: March 18, 2003. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy.
FR Doc. 03-7145 Filed 3-25-03; 8:45 amBILLING CODE 4140-01-M
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United States
Explore vLex
For Professionals
For Partners
Company
Other documents:
20 cfr 411.180 what is timely progress toward self-supporting employment? | 5 CFR 178.203 - Designation of beneficiary. | Bristol v Board of County Commissioners of County of Clear Creek 10th Cir 2002 | US v Howie 4th Cir 1999 | Sentencia nº 1242 de Consiglio di Stato, March 16, 2011 | sentencia nº 5230 de consiglio di stato, october 21, 2009 | decisión nº pj0652012000164-12 de tribunal segundo en funciones de control con competencia en materia de delitos de violencia contra... | Sentencia nº 81 de Consiglio di Stato, November 06, 2009